title: Can a rational design for metronomic chemotherapy dosing be devised?
authors.forename: A
authors.initials: A
authors.lastname: Maraveyas
authors.forename: T
authors.initials: T
authors.lastname: Lam
authors.forename: J W
authors.initials: JW
authors.lastname: Hetherington
authors.forename: J
authors.initials: J
authors.lastname: Greenman
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy*; D012107:Research Design / Q000592:standards*
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents